Among them, IP-10 had the largest AUC of 0.715, indicating that IP-10 is the most effective in evaluating the clinical prognosis of COVID-19 patients, with its predictive efficacy superior to that of the common inflammatory marker NLR. This evidence concerns the gene CXCL10 and COVID-19.